Plasma prostaglandins across the tumor bed of patients with gynecologic malignancy

R. Mortel, J. C. Allegra, Laurence Demers, Harold Harvey, J. Trautlein, W. Nahhas, D. White, M. A. Gillinrn, Allan Lipton

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Prostaglandin E produced by tumors has recently been implicated as a mechanism by which tumors may subvert the immune system and grow despite their antigenicity. Arterial and venous determinations of prostaglandin E were performed in eleven patients with gynecologic malignancy. No significant difference was found when arterial and venous levels were compared and there was no difference in venous PGE levels when subjects with cancer were compared to patients with benign gynecologic disease.

Original languageEnglish (US)
Pages (from-to)2201-2203
Number of pages3
JournalCancer
Volume39
Issue number5
DOIs
StatePublished - Jan 1 1977

Fingerprint

Prostaglandins
Prostaglandins E
Neoplasms
Female Genital Diseases
Immune System

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Mortel, R. ; Allegra, J. C. ; Demers, Laurence ; Harvey, Harold ; Trautlein, J. ; Nahhas, W. ; White, D. ; Gillinrn, M. A. ; Lipton, Allan. / Plasma prostaglandins across the tumor bed of patients with gynecologic malignancy. In: Cancer. 1977 ; Vol. 39, No. 5. pp. 2201-2203.
@article{f1e4e16f554440fea5debdeb792a9446,
title = "Plasma prostaglandins across the tumor bed of patients with gynecologic malignancy",
abstract = "Prostaglandin E produced by tumors has recently been implicated as a mechanism by which tumors may subvert the immune system and grow despite their antigenicity. Arterial and venous determinations of prostaglandin E were performed in eleven patients with gynecologic malignancy. No significant difference was found when arterial and venous levels were compared and there was no difference in venous PGE levels when subjects with cancer were compared to patients with benign gynecologic disease.",
author = "R. Mortel and Allegra, {J. C.} and Laurence Demers and Harold Harvey and J. Trautlein and W. Nahhas and D. White and Gillinrn, {M. A.} and Allan Lipton",
year = "1977",
month = "1",
day = "1",
doi = "10.1002/1097-0142(197705)39:5<2201::AID-CNCR2820390538>3.0.CO;2-9",
language = "English (US)",
volume = "39",
pages = "2201--2203",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

Plasma prostaglandins across the tumor bed of patients with gynecologic malignancy. / Mortel, R.; Allegra, J. C.; Demers, Laurence; Harvey, Harold; Trautlein, J.; Nahhas, W.; White, D.; Gillinrn, M. A.; Lipton, Allan.

In: Cancer, Vol. 39, No. 5, 01.01.1977, p. 2201-2203.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Plasma prostaglandins across the tumor bed of patients with gynecologic malignancy

AU - Mortel, R.

AU - Allegra, J. C.

AU - Demers, Laurence

AU - Harvey, Harold

AU - Trautlein, J.

AU - Nahhas, W.

AU - White, D.

AU - Gillinrn, M. A.

AU - Lipton, Allan

PY - 1977/1/1

Y1 - 1977/1/1

N2 - Prostaglandin E produced by tumors has recently been implicated as a mechanism by which tumors may subvert the immune system and grow despite their antigenicity. Arterial and venous determinations of prostaglandin E were performed in eleven patients with gynecologic malignancy. No significant difference was found when arterial and venous levels were compared and there was no difference in venous PGE levels when subjects with cancer were compared to patients with benign gynecologic disease.

AB - Prostaglandin E produced by tumors has recently been implicated as a mechanism by which tumors may subvert the immune system and grow despite their antigenicity. Arterial and venous determinations of prostaglandin E were performed in eleven patients with gynecologic malignancy. No significant difference was found when arterial and venous levels were compared and there was no difference in venous PGE levels when subjects with cancer were compared to patients with benign gynecologic disease.

UR - http://www.scopus.com/inward/record.url?scp=0017711198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017711198&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197705)39:5<2201::AID-CNCR2820390538>3.0.CO;2-9

DO - 10.1002/1097-0142(197705)39:5<2201::AID-CNCR2820390538>3.0.CO;2-9

M3 - Article

C2 - 858131

AN - SCOPUS:0017711198

VL - 39

SP - 2201

EP - 2203

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -